Legal Opinion
Biodelivery Scis. Int'l, Inc. v. Aquestive Therapeutics, Inc.
Court of Appeals for the Federal Circuit
Decided July 31, 2018No. 2017-1265; 2017-1266; 2017-1268PublishedCited by 18 opinions
1Opinion of the Court
Newman, Circuit Judge.
ORDER
BioDelivery Sciences International, Inc. ("BioDelivery") moves to remand this case to the Patent Trial and Appeal Board to consider non-instituted claims and non-instituted grounds in accordance with the Supreme Court's recent decision in SAS Institute, Inc. v. Iancu , --- U.S. ----, 138 S.Ct. 1348 , 200 L.Ed.2d 695 (2018). Aquestive Therapeutics, Inc. ("Aquestive") and the PTO Director, who has intervened, oppose. Having considered the parties' arguments and our recent decisions interpreting SAS and requests based thereon, we remand .
DISCUSSION
BioDelivery filed…
2Cases cited8 opinions
- Catlin v. United StatesSupreme Court of the United States · 1945
- Hormel v. HelveringSupreme Court of the United States · 1941
- SAS Institute Inc. v. IancuSupreme Court of the United States · 2018
- In Re: Micron Technology, Inc.Court of Appeals for the Federal Circuit · 2017
- PGS GEOPHYSICAL AS v. IANCUCourt of Appeals for the Federal Circuit · 2018
3 more not listed; retrieve them via the Exa API.
3Cited by18 opinions
- Sionyx, LLC v. Hamamatsu Photonics K.K.District Court, District of Columbia · 2018
- Yeda Research and Development v. Mylan Pharmaceuticals Inc.Court of Appeals for the Federal Circuit · 2018
- Palomar Techs., Inc. v. Mrsi Sys., LLCDistrict Court, District of Columbia · 2019
- Click-To-Call Technologies, Lp v. Ingenio, Inc.Court of Appeals for the Federal Circuit · 2022
- Biodelivery Scis. Int'l, Inc. v. Aquestive Therapeutics, Inc.Court of Appeals for the Federal Circuit · 2019
13 more not listed; retrieve them via the Exa API.